4//SEC Filing
deVries Tina Marie 4
Accession 0001104659-20-064437
CIK 0001739426other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 9:48 PM ET
Size
7.5 KB
Accession
0001104659-20-064437
Insider Transaction Report
Form 4
deVries Tina Marie
EVP, Research & Development
Transactions
- Award
Performance-Based Restricted Stock Units
2020-05-18+71,550→ 71,550 total→ Ordinary Shares (71,550 underlying) - Award
Ordinary Shares
2020-05-18+71,550→ 167,259 total
Footnotes (2)
- [F1]Represents a grant of restricted stock units.
- [F2]The performance-based restricted stock units represent a contingent right to receive, upon vesting, a varying number of the registrant's ordinary shares based on certain pre-determined thresholds for the closing price of registrant's ordinary shares on the Nasdaq Global Select Market. The performance-based restricted stock units vest on the third anniversary of the date of grant and, upon vesting, will convert into 0%, 50%, 100% or 150% of the target number of ordinary shares listed in Column 7 of Table II.
Documents
Issuer
Osmotica Pharmaceuticals plc
CIK 0001739426
Entity typeother
Related Parties
1- filerCIK 0001750589
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 9:48 PM ET
- Size
- 7.5 KB